{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:10:44Z","timestamp":1792858244113,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | Center for Scientific Review","award":["P30-EY026877"],"award-info":[{"award-number":["P30-EY026877"]}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We propose a hybrid sequential prediction model called \u201cDeep Sequence\u201d, integrating radiomics-engineered imaging features, demographic, and visual factors, with a recursive neural network (RNN) model in the same platform to predict the risk of exudation within a future time-frame in non-exudative AMD eyes. The proposed model provides scores associated with risk of exudation in the short term (within 3\u00a0months) and long term (within 21\u00a0months), handling challenges related to variability of OCT scan characteristics and the size of the training cohort. We used a retrospective clinical trial dataset that includes 671 AMD fellow eyes with 13,954 observations before any signs of exudation for training and validation in a tenfold cross validation setting. Deep Sequence achieved high performance for the prediction of exudation within 3\u00a0months (0.96\u2009\u00b1\u20090.02 AUCROC) and within 21\u00a0months (0.97\u2009\u00b1\u20090.02 AUCROC) on cross-validation. Training the proposed model on this clinical trial dataset and testing it on an external real-world clinical dataset showed high performance for the prediction within 3-months (0.82 AUCROC) but a clear decrease in performance for the prediction within 21-months (0.68 AUCROC). While performance differences at longer time intervals may be derived from dataset differences, we believe that the high performance and generalizability achieved in short-term predictions may have a high clinical impact allowing for optimal patient follow-up, adding the possibility of more frequent, detailed screening and tailored treatments for those patients with imminent risk of exudation.<\/jats:p>","DOI":"10.1038\/s41598-020-72359-y","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T06:04:02Z","timestamp":1600754642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Prediction of age-related macular degeneration disease using a sequential deep learning approach on longitudinal SD-OCT imaging biomarkers"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3327-8004","authenticated-orcid":false,"given":"Imon","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"de Sisternes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle A.","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8461-3562","authenticated-orcid":false,"given":"Theodore","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7512-4751","authenticated-orcid":false,"given":"Aaron","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5057-4369","authenticated-orcid":false,"given":"Daniel","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"72359_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.amepre.2013.02.018","volume":"45","author":"C-F Chou","year":"2013","unstructured":"Chou, C.-F. et al. Age-related eye diseases and visual impairment among U.S. adults. Am. J. Prev. Med. 45, 29\u201335 (2013).","journal-title":"Am. J. Prev. Med."},{"key":"72359_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2, e106\u2013e116 (2014).","journal-title":"Lancet Glob. Health"},{"key":"72359_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bjophthalmol-2013-304033","volume":"98","author":"RRA Bourne","year":"2014","unstructured":"Bourne, R. R. A. et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990\u20132010. Br. J. Ophthalmol. 98, 629\u2013638 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"72359_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/aos.13989","volume":"97","author":"S Aurell","year":"2019","unstructured":"Aurell, S., Sj\u00f6vall, K., Paul, A., Mor\u00e9n, \u00c5 & Granstam, E. Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat-and-extend compared with pro re nata in eyes with neovascular age-related macular degeneration. Acta Ophthalmol. 97, 519\u2013524 (2019).","journal-title":"Acta Ophthalmol."},{"key":"72359_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/bjophthalmol-2016-308422","volume":"101","author":"FG Schlanitz","year":"2017","unstructured":"Schlanitz, F. G. et al. Drusen volume development over time and its relevance to the course of age-related macular degeneration. Br. J. Ophthalmol. 101, 198\u2013203 (2017).","journal-title":"Br. J. Ophthalmol."},{"key":"72359_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.07.004","author":"U Schmidt-Erfurth","year":"2018","unstructured":"Schmidt-Erfurth, U., Sadeghipour, A., Gerendas, B. S., Waldstein, S. M. & Bogunovi\u0107, H. Artificial intelligence in retina. Prog. Retin. Eye Res. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.07.004 (2018).","journal-title":"Prog. Retin. Eye Res."},{"key":"72359_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.oret.2016.12.009","volume":"1","author":"CS Lee","year":"2017","unstructured":"Lee, C. S., Baughman, D. M. & Lee, A. Y. Deep learning is effective for classifying normal versus age-related macular degeneration OCT images. Ophthalmol. Retina 1, 322\u2013327 (2017).","journal-title":"Ophthalmol. Retina"},{"key":"72359_CR8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","volume":"24","author":"J De Fauw","year":"2018","unstructured":"De Fauw, J. et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat. Med. 24, 1342\u20131350 (2018).","journal-title":"Nat. Med."},{"key":"72359_CR9","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1167\/iovs.14-14918","volume":"55","author":"L de Sisternes","year":"2014","unstructured":"de Sisternes, L., Simon, N., Tibshirani, R., Leng, T. & Rubin, D. L. Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression. Investig. Opthalmol. Vis. Sci. 55, 7093 (2014).","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"72359_CR10","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1167\/iovs.18-24106","volume":"59","author":"U Schmidt-Erfurth","year":"2018","unstructured":"Schmidt-Erfurth, U. et al. Prediction of individual disease conversion in early AMD using artificial intelligence. Investig. Opthalmol. Vis. Sci. 59, 3199 (2018).","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"72359_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/1479-7364-5-5-420","volume":"5","author":"GS Hageman","year":"2011","unstructured":"Hageman, G. S. et al. Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Hum. Genomics 5, 420 (2011).","journal-title":"Hum. Genomics"},{"key":"72359_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ng.2578","volume":"45","author":"The AMD Gene Consortium","year":"2013","unstructured":"The AMD Gene Consortium. Seven new loci associated with age-related macular degeneration. Nat. Genet. 45, 433\u2013439 (2013).","journal-title":"Nat. Genet."},{"key":"72359_CR13","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1167\/iovs.14-15841","volume":"56","author":"JM Seddon","year":"2015","unstructured":"Seddon, J. M., Silver, R. E., Kwong, M. & Rosner, B. Risk prediction for progression of macular degeneration: 10 common and rare genetic variants, demographic, environmental, and macular covariates. Investig. Ophthalmol. Vis. Sci. 56, 2192 (2015).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"72359_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/RTI.0000000000000485","volume":"35","author":"M van Assen","year":"2020","unstructured":"van Assen, M., Banerjee, I. & De Cecco, C. N. Beyond the artificial intelligence hype: what lies behind the algorithms and what we can achieve. J. Thorac. Imaging 35, S3\u2013S10 (2020).","journal-title":"J. Thorac. Imaging"},{"key":"72359_CR15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: images are more than pictures, they are data. Radiology 278, 563\u2013577 (2016).","journal-title":"Radiology"},{"key":"72359_CR16","volume-title":"Analysis of Survival Data","author":"DR Cox","year":"1984","unstructured":"Cox, D. R. & Oakes, D. Analysis of Survival Data (Chapman and Hall, New York, 1984)."},{"key":"72359_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/jamaophthalmol.2014.4252","volume":"133","author":"RE Gangnon","year":"2015","unstructured":"Gangnon, R. E. et al. Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the beaver dam eye study. JAMA Ophthalmol. 133, 125 (2015).","journal-title":"JAMA Ophthalmol."},{"key":"72359_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1001\/jamaophthalmol.2019.0868","volume":"137","author":"JA Hallak","year":"2019","unstructured":"Hallak, J. A. et al. Imaging, genetic, and demographic factors associated with conversion to neovascular age-related macular degeneration: secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 137, 738 (2019).","journal-title":"JAMA Ophthalmol."},{"key":"72359_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.6.1.12","volume":"6","author":"L de Sisternes","year":"2017","unstructured":"de Sisternes, L. et al. Individual Drusen segmentation and repeatability and reproducibility of their automated quantification in optical coherence tomography images. Transl. Vis. Sci. Technol. 6, 12 (2017).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"72359_CR20","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1162\/neco.1997.9.8.1735","volume":"9","author":"S Hochreiter","year":"1997","unstructured":"Hochreiter, S. & Schmidhuber, J. Long short-term memory. Neural Comput. 9, 1735\u20131780 (1997).","journal-title":"Neural Comput."},{"key":"72359_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27946-5","author":"I Banerjee","year":"2018","unstructured":"Banerjee, I. et al. Probabilistic prognostic estimates of survival in metastatic cancer patients (PPES-Met) utilizing free-text clinical narratives. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-27946-5 (2018).","journal-title":"Sci. Rep."},{"key":"72359_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"LB Breiman","year":"2001","unstructured":"Breiman, L. B. Random Forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"72359_CR23","first-page":"983","volume":"7","author":"N Meinshausen","year":"2006","unstructured":"Meinshausen, N. Quantile regression forests. J. Mach. Learn. Res. 7, 983\u2013999 (2006).","journal-title":"J. Mach. Learn. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72359-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:55:50Z","timestamp":1670338550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72359-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72359"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72359-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"9 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors LdS and DR: issue of patent US9737205B2 for evaluating the progression of age-related macular degeneration. The rest of the authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15434"}}